Literature DB >> 23684847

Comparison of initial feasibility of host cell lines for viral vaccine production.

Danielle H W Vlecken1, Ralf P M Pelgrim, Slawomir Ruminski, Wilfried A M Bakker, Leo A van der Pol.   

Abstract

In order to reduce the time required for the development and production of viral vaccines, host cell lines should be available as expression systems for production of viral vaccines against groups of viral pathogens. A selection of cell lines was compared for their initial feasibility as expression system for the replication of polioviruses, influenza A viruses and respiratory syncytial virus (wild type strain A2). Six adherent cell lines (Vero, HEK-293, MRC-5, CHO-K1, BHK-21 c13, MDCK) and six single cell suspension cell lines (CAP, AGE1.CR.HS, sCHO-K1, BHK-21 c13 2p, MDCK SFS) were studied for their ability to propagate viruses. First, maximum cell densities were determined. Second, virus receptor expression and polarization of the cell lines regarding receptor distribution of eight different viruses were monitored using flow cytometry and immunocytochemistry. Organization of the actin cytoskeleton was studied by transfection of the cells with Lifeact™, a construct coding for actin-EGFP. Finally, the ability to produce virus progeny of the viruses studied was assayed for each cell line. The results suggest that single cell suspension cell lines grown on serum free medium are the best candidates to serve as host cell lines for virus replication.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Host cell line; Influenza; Polio; RSV; Virus cultivation; Virus receptor

Mesh:

Substances:

Year:  2013        PMID: 23684847     DOI: 10.1016/j.jviromet.2013.04.020

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  Proteomic analysis of membrane proteins of vero cells: exploration of potential proteins responsible for virus entry.

Authors:  Donghua Guo; Qinghe Zhu; Hong Zhang; Dongbo Sun
Journal:  DNA Cell Biol       Date:  2013-11-28       Impact factor: 3.311

Review 2.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Cell culture-derived flu vaccine: Present and future.

Authors:  Alberto Pérez Rubio; Jose María Eiros
Journal:  Hum Vaccin Immunother       Date:  2018-06-28       Impact factor: 3.452

4.  Enhanced production of human influenza virus in PBS-12SF cells with a reduced interferon response.

Authors:  Monica Carvajal-Yepes; Kelly R B Sporer; Jenna L Carter; Christopher J Colvin; Paul M Coussens
Journal:  Hum Vaccin Immunother       Date:  2015-06-19       Impact factor: 3.452

5.  Enhancing the yield of seasonal influenza viruses through manipulation of microRNAs in Madin-Darby canine kidney cells.

Authors:  Suthat Saengchoowong; Pattaraporn Nimsamer; Kritsada Khongnomnan; Witthaya Poomipak; Kesmanee Praianantathavorn; Somruthai Rattanaburi; Yong Poovorawan; Qibo Zhang; Sunchai Payungporn
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

6.  Hematopoietic cancer cell lines can support replication of Sabin poliovirus type 1.

Authors:  Dinja Oosterhoff; Gerard van de Weerd; Gerco van Eikenhorst; Tanja D de Gruijl; Leo A van der Pol; Wilfried A M Bakker
Journal:  Biomed Res Int       Date:  2015-02-28       Impact factor: 3.411

7.  Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine.

Authors:  Jingliang Li; Guanchen Liu; Xin Liu; Jiaxin Yang; Junliang Chang; Wenyan Zhang; Xiao-Fang Yu
Journal:  Viruses       Date:  2015-07-17       Impact factor: 5.048

8.  A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time.

Authors:  Gilberto Gonzàlez-Parra; Filip De Ridder; Dymphy Huntjens; Dirk Roymans; Gabriela Ispas; Hana M Dobrovolny
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 9.  Novel Approaches for The Development of Live Attenuated Influenza Vaccines.

Authors:  Pilar Blanco-Lobo; Aitor Nogales; Laura Rodríguez; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2019-02-22       Impact factor: 5.048

10.  Adenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication.

Authors:  Natascha Krömmelbein; Lüder Wiebusch; Gudrun Schiedner; Nicole Büscher; Caroline Sauer; Luise Florin; Elisabeth Sehn; Uwe Wolfrum; Bodo Plachter
Journal:  Viruses       Date:  2016-02-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.